Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Daewoong Pharmaceutical Co. LTD..
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Daewoong Pharmaceutical Co. LTD.
ClinicalTrials.gov Identifier:
NCT01635686
First received: July 4, 2012
Last updated: July 25, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)